In this week’s Analysis – Global Biotechnology!
Aksjeanalyser.com look’s at a Biotech share on the Oslo Stock Exchange!
Further price increase for the share is signaled both in the short and longer term!
Aker BioMarine (ticker on Oslo Stock Exchange: AKBM)
Read more about the stock below in this week’s Analysis from Vikingen Financial Software and Aksjeanalyser.com.
First, a brief description of the company, Aker BioMarine ASA (ticker on the Oslo Stock Exchange: AKBM)
Aker BioMarine is a biotechnology company that specializes in the development of dietary supplements. The product portfolio is broad and includes, for example, omega-3 oil, dietary supplements for animals and protein supplements for fish farming. The company operates globally with the largest presence in the Nordic market. Customers consist of both private operators and wholesalers. Aker BioMarine was founded in 2006 and is headquartered in Oslo.
For more information about the company, visit their website.
Technical Analysis of Aker BioMarine ASA
Aker BioMarine (ticker on Oslo Børs: AKBM) share shows a strong development within a long-term rising trend, which started at the end of 2023 (see weekly chart).

The stock is now triggering new positive technical signals, breaking up from a consolidation formation, and rising above previous all-time-high from back in early 2021.
Various momentum indicators, such as RSI and MACD, also signal further increases for the stock.
The stock is above both the 50-day and 200-day moving averages, and the 50-day moving average is above the 200-day moving average. This confirms that both the short-term and long-term trend for the stock is positive.
There is now little technical resistance for further upside for the share, and according to the long-term positive trend within which the share is moving, a potential of around NOK 120.00 – 140.00 in 6-12 months’ time is indicated.
Aker BioMarine has potential to double the stock price within 12 months!

The BEST model in Vikingen is also in a buy signal for the Aker BioMarine stock. This popular and effective technical analysis model was developed by Peter Östevik. He finalized the the BEST model around 2019, and after 30 years of experience with technical analysis and Vikingen Financial Software.
What could possibly change the positive technical picture would be if the share was to break down below the 50-day moving average (which is currently around NOK 65.00) and below an important technical support level around NOK 60.00.
Based on the overall very positive technical picture shown by Aker BioMarine (AKBM), Aksjeanalyser.com considers the stock to be a very interesting and exciting buy candidate. In other words, the stock is considered to have the potential to double in value over the next 12 months or so.
Below you find some current news about the company, Aker BioMarine (AKBM):
AKBM: ADJUSTED EBITDA USD 7.4M IN Q4 2024 (2.5)
Oslo (Infront TDN Direkt): Aker Biomarine achieved an adjusted ebitda of USD 7.4 million in the fourth quarter of 2024, compared to USD 2.5 million in the same period last year. This is stated in the company’s quarterly report on Wednesday. The company had net sales of USD 52 million in the period (48.8), while operating profit was USD -3.2 million in the quarter (-8.2).
AKBM: WILL PAY EX. DIVIDEND OF CA. 45/SHARE AFTER COMPLETION OF THE FEED INGREDIENTS TRANSACTION
September 3, 2024 15:43 ∙ TDN Finance
Oslo (Infront TDN Direkt): Aker Biomarine has completed the sale of its Feed Ingredients business to American Industrial Partners and Aker Capital AS. This is stated in a press release on Tuesday. Total gross proceeds amount to USD 630 million, of which USD 610 million has been settled today and USD 20 million will be settled within 90 days. The net proceeds to Aker BioMarine after debt and costs will be 227 million dollars. Following the transaction, the company intends to distribute an extraordinary dividend of approximately NOK 45 per share, subject to final board approval.
Aker BioMarine – Declaration of extraordinary dividend
September 5, 2024 11:31 ∙ Oslo Stock Exchange
September 5, 2024: The Board of Directors has today resolved to distribute an
extraordinary dividend of NOK 45 per share. Key information relating to the
dividend payment:
Extraordinary cash dividend: 45. Declared currency: NOK
Last day including rights: September 6, 2024. Ex-date: September 9, 2024
Don’t miss Vikingen’s offers!
To get access to the BEST Model in Vikingen you need Vikingen Exchange, Vikingen Trading or Vikingen Maxi. By using the code FEB20 you get 20% on these programs for the whole month of February! Welcome to Vikingen!
Do you already have Vikingen, but want an interesting addition? See all the additions here.
Maybe you want all the shares on the Oslo Stock Exchange? You can find them here!
You’ll also get a 20% discount on Vikingen’s add-on’s until February 28, 2025. Use the code FEB20
These offers can only be used once per person and not together, but only separately.
Here you can watch free trainings (in Swedish) about Vikingen Mini, Börs,Trading and Vikingen Maxi programs.
Vikingen Financial Software reminds you that past positive results do not always indicate future profits and that all trading is at your own risk.
Sincerely yours